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Sodium excretion is associated with increased blood pressure. The 
INTERSALT study revealed a significant linear relationship between the 
median 24-hour urinary sodium excretion in 52 centers and the slope of systolic 
blood pressure with age in age and sex-standardized analysis 1. A pooled 
analysis of the results of four large studies, the PURE, EPIDREAM, 
ONTARGET and TRANSCEND studies, also showed that the estimated 
24-hour urinary sodium excretion was associated with increased systolic and 
diastolic pressure 2.  
However, the association between urinary sodium excretion and cardiovascular 
events remains controversial. The above-mentioned pooled analysis showed that 
salt restriction reduced the risk of cardiovascular events and death in 
populations with hypertension and that an association of extensively low 
sodium intake with increased risk of cardiovascular events and death is 
observed in those with or without hypertension 2. Meanwhile, the Trials of 
Hypertension Prevention ( TOHP) showed an increased risk of mortality for 
individuals with high sodium intake and a direct relationship with total 
mortality, even at the lowest levels of sodium intake 3. Therefore, the optimal 
level of sodium intake has been unclear. 
Reduction of sodium intake is recommended in the guidelines of the 
European Society of Hypertension, American Heart Association, Japanese 
Society of Hypertension and WHO 4-6. Although the optimal level of sodium 
intake is controversial, a sodium reduction program is likely to be beneficial for 
prevention of cardiovascular diseases in communities in which people consume 
  
3 
high amounts of salt 7. The UK initiated a nationwide salt reduction program in 
2003/2004, which was successful and resulted in a 15% reduction in population 
salt intake by 2011 (from 9.5 g/day in 2003 to 8.1 g/day in 2011). The Health 
Survey for England conducted from 2003 to 2011 showed decreases of 42% and 
40% in the mortality rates of stroke and ischemic heart disease, respectively, 
along with decreases in systolic/diastolic blood pressure of 3.0/1.4 mmHg. A 
recent community-level prospective epidemiological cohort study showed that 
sodium intake was associated with cardiovascular disease and stroke only in 
communities in which the mean sodium intake was more than 5 g/day 8. Data 
from a prospective cohort study of a Chinese population also showed that high 
urinary sodium excretion was independently associated with an increased risk of 
cardiovascular disease 9. Japan is a country in which people consume a large 
amount of salt. The National Health and Nutrition Survey in Japan, 2017 
showed that the mean dietary salt intake in the period from 2007 to 2017 was 
9.9 g/day (https://www.mhlw.go.jp/bunya/kenkou/kenkou_eiyou_chousa.html). 
The ESPRIT study, a prospective observational study, showed that, in Japan, 
high sodium excretion (≥ 4.0 g/day) was associated with composite 
cardiovascular events including hospitalization due to heart failure, acute 
coronary syndrome, cerebrovascular events and cardiovascular deaths 10. It 
seems difficult to determine the optimal amount of salt intake, but a strategy of 
sodium reduction would be appropriate in communities in which people prefer 
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